DexCom
DXCM
175 hedge funds and large institutions have $1.94B invested in DexCom in 2013 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 55 increasing their positions, 72 reducing their positions, and 12 closing their positions.
150% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 12
19% more capital invested
Capital invested by funds: $1.63B → $1.94B (+$311M)
11% more funds holding
Funds holding: 158 → 175 (+17)
24% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 72
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
91% less call options, than puts
Call options by funds: $1.55M | Put options by funds: $16.9M
Top Buyers
Top Sellers
DXCM Hedge Fund Activity: Q3 2013 in Review
175 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q3 2013, worth a combined $1.94B — up 19% from $1.63B a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new DXCM positions and 12 closed out — a net gain of 18 holders — while 55 added to existing stakes and 72 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $25.5M. The largest seller was Federated Hermes, cutting an estimated $44.5M.
- 175 institutional investors held DexCom (DXCM) as of Q3 2013, up from 158 in Q2 2013.
- Funds reported $1.94B of DexCom stock for Q3 2013, up 19% quarter-over-quarter.
- 30 funds opened new DexCom positions in Q3 2013 and 12 closed out, a net change of +18 holders.
- The largest DexCom buyer in Q3 2013 was Wellington Management Group, an estimated $25.5M added.
- The largest DexCom seller in Q3 2013 was Federated Hermes, an estimated $44.5M sold.
Based on aggregated 13F filings for Q3 2013.